Drug Chatter -- Tracking biopharma stock chatter

Profile for Galectin Therapeutics Inc. (GALT)

« Back to company index

GALT Chatter Timeline

Stock Ticker for GALT

Most Active Tweeters for GALT

UserTweets
@SPNewsAnalysis 4
@biotech_sector 4
@DrTranBioSci 4
@chaffeybreeze 3
@intercooleronli 2

Recent Tweets for GALT

MenachemSherman @MenachemSherman
$GALT might dip lower but it has that 5x potential with anything better than a complete fail of the NASH-CX trial. Will be a wild end of yr.
July 27th 2017, 5:07pm
dakotafinancial @dakotafinancial
Galectin Therapeutics $GALT vs. Biohaven Pharmaceutical Holding Co $BHVN Critical Contrast https://t.co/nQiBwiLhwI
July 25th 2017, 9:07pm
kyookine @kyookine
Galectin nabs U.S. patent covering lead candidate GR-MD-02; shares ahead 8% https://t.co/er5UQfsDYZ $GALT
July 25th 2017, 6:07pm
DrTranBioSci @DrTranBioSci
The value of Galectin resides elsewhere rather than NASH. $GALT https://t.co/3xpgaFvnUH
July 25th 2017, 5:07pm
DrTranBioSci @DrTranBioSci
Galectin stock gained +6% today. The firm received the patent for immunotherapy enhancing re: cancer rx. $GALT https://t.co/3xpgaFvnUH
July 25th 2017, 5:07pm
RyanHooshmand @RyanHooshmand
RT @biotech_sector: Patent For Enhancing Immunotherapy In Cancer Treatment Granted To #Galectin . Read more: https://t.co/btNv3SzLlB $GALT
July 25th 2017, 3:07pm
biotech_sector @biotech_sector
Patent For Enhancing Immunotherapy In Cancer Treatment Granted To #Galectin . Read more: https://t.co/btNv3SzLlB $GALT
July 25th 2017, 3:07pm
tickerws @tickerws
$GALT nabs U.S. patent covering lead candidate GR-MD-02; shares +13% https://t.co/7a0Zyi119l
July 25th 2017, 11:07am
mITYFX @mITYFX
RT @MarketCurrents: Galectin nabs U.S. patent covering lead candidate GR-MD-02; shares ahead 8% https://t.co/8sQASwMCCb $GALT
July 25th 2017, 11:07am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Galectin nabs U.S. patent covering lead candidate GR-MD-02; shares ahead 8% https://t.co/78nearEn4B $GALT
July 25th 2017, 11:07am
MarketCurrents @MarketCurrents
Galectin nabs U.S. patent covering lead candidate GR-MD-02; shares ahead 8% https://t.co/8sQASwMCCb $GALT
July 25th 2017, 11:07am
biotech_sector @biotech_sector
Patent for Enhancing Immunotherapy in Cancer Treatment Granted to #Galectin Therapeutics. Read more: https://t.co/4eqg5Gc0fL $GALT
July 25th 2017, 11:07am
trendcache @trendcache
Trending #Biotech topics include $GALT, $OKTA, #Cimzia #stocks #invest See more https://t.co/EpbbdqDEG1
July 25th 2017, 10:07am
Briefingcom @Briefingcom
$GALT: Galectin Therapeutics receives NOA for a US patent that provides intellectual property protection for the... https://t.co/TIx85hXP5c
July 25th 2017, 10:07am
pgtraber @pgtraber
RT @GalectinGALT: Patent for enhancing #immunotherapy treatment in #cancer granted to $GALT https://t.co/KQMjZrAbM1
July 25th 2017, 9:07am
GalectinGALT @GalectinGALT
Patent for enhancing #immunotherapy treatment in #cancer granted to $GALT https://t.co/KQMjZrAbM1
July 25th 2017, 9:07am
stockboardinc @stockboardinc
$GALT Patent for Enhancing Immunotherapy in Cancer Treatment Granted to Galectin Therapeutics... - https://t.co/B8u4ykXbY2
July 25th 2017, 8:07am
newswithvalue @newswithvalue
$GALT: Patent for Enhancing Immunotherapy in Cancer Treatment Granted …: https://t.co/0Zt1bEhnNE
July 25th 2017, 8:07am
MrPretender1 @MrPretender1
$GALT - Patent for Enhancing Immunotherapy in Cancer Treatment Granted to Galectin Therapeutics https://t.co/ChSYWuCJEX
July 25th 2017, 8:07am
Allstocknews @Allstocknews
$GALT Patent for Enhancing Immunotherapy in Cancer Treatment Granted to Galectin Therapeutics From our Stock News Alerts App
July 25th 2017, 8:07am
GNWLive @GNWLive
Patent for Enhancing Immunotherapy in Cancer Treatment Granted to Galectin Therapeutics $GALT https://t.co/7MmMQybry6
July 25th 2017, 8:07am
SleekMoneycom @SleekMoneycom
Head-To-Head Review: Galectin Therapeutics $GALT & Biohaven Pharmaceutical Holding Co $BHVN https://t.co/O8Kd4Rnrc5
July 23rd 2017, 3:07pm
SPNewsAnalysis @SPNewsAnalysis
Biohaven Pharmaceutical Holding Co $BHVN & Galectin Therapeutics $GALT Critical Review https://t.co/9qgygBzk5q
July 23rd 2017, 3:07pm
storminvestor @storminvestor
Biohaven Pharmaceutical Holding Co $BHVN & Galectin Therapeutics $GALT Critical Review https://t.co/K7YZAGBWtD
July 23rd 2017, 3:07pm
biotech_sector @biotech_sector
#Galectin Therapeutics Inc Medical Equipment Deals and Alliances Profile Report Updated 1... Read more: https://t.co/86lKrrevW6 $GALT
July 22nd 2017, 1:07pm
WatchlistN @WatchlistN
Zacks Investment Research Lowers Galectin Therapeutics Inc. $GALT to Hold https://t.co/etc8XUTFuo
July 22nd 2017, 1:07pm
ZolmaxNews @ZolmaxNews
Zacks Investment Research Lowers Galectin Therapeutics Inc. $GALT to Hold https://t.co/Hk2In8ZTTg
July 22nd 2017, 1:07pm
SPNewsAnalysis @SPNewsAnalysis
Galectin Therapeutics Inc. $GALT Downgraded by Zacks Investment Research https://t.co/F0sgXKazVY
July 21st 2017, 3:07pm
storminvestor @storminvestor
Galectin Therapeutics Inc. $GALT Downgraded by Zacks Investment Research https://t.co/Ue5JMd5iSs
July 21st 2017, 3:07pm
TheMarketsDaily @TheMarketsDaily
Zacks Investment Research Downgrades Galectin Therapeutics Inc. $GALT to Hold https://t.co/yD1CaqMxFt
July 20th 2017, 9:07am
dailypoliticaln @dailypoliticaln
Galectin Therapeutics Inc. $GALT Downgraded by Zacks Investment Research https://t.co/3JpfT9BK1S
July 20th 2017, 8:07am
midetimes @midetimes
Galectin Therapeutics Inc. $GALT Downgraded by Zacks Investment Research https://t.co/vHvXQqRiin
July 20th 2017, 8:07am
biotech_sector @biotech_sector
#Galectin Therapeutics Inc Medical Equipment Deals and Alliances Profile Report Updated 1... Read more: https://t.co/1GhVPyOtdv $GALT
July 20th 2017, 2:07am
DrTranBioSci @DrTranBioSci
Galectin is up +2.18%. Despite promising data for psoriasis, its prospects remain in NASH. Will it perform? $GALT https://t.co/3xpgaFvnUH
July 19th 2017, 5:07pm
dakotafinancial @dakotafinancial
Galectin Therapeutics Inc. $GALT Downgraded by Zacks Investment Research to “Hold” https://t.co/3B1RXwyJIS
July 19th 2017, 1:07pm
chaffeybreeze @chaffeybreeze
Galectin Therapeutics Inc. $GALT Cut to Hold at Zacks Investment Research https://t.co/qv8RoH32OX
July 18th 2017, 11:07pm
IRAMarketReport @IRAMarketReport
Galectin Therapeutics Inc. $GALT Cut to Hold at Zacks Investment Research https://t.co/gqAgDQ5X58
July 18th 2017, 11:07pm
TickerReport @TickerReport
Galectin Therapeutics Inc. $GALT Cut to Hold at Zacks Investment Research https://t.co/71TdBe96Wg
July 18th 2017, 11:07pm
emq_news @emq_news
Galectin Therapeutics Inc. $GALT Cut to Hold at Zacks Investment Research https://t.co/h7tOWMTdum
July 18th 2017, 11:07pm
TickerReport @TickerReport
Galectin Therapeutics Inc. $GALT Cut to Hold at Zacks Investment Research https://t.co/MZbqlGwIyx
July 18th 2017, 11:07pm
RatingsNetwork @RatingsNetwork
Galectin Therapeutics downgraded by Zacks Investment Research to hold. https://t.co/RkROSkzhsk $GALT #GALT
July 18th 2017, 11:07pm
ZolmaxNews @ZolmaxNews
Galectin Therapeutics $GALT & Biohaven Pharmaceutical Holding Co $BHVN Head-To-Head Comparison https://t.co/eJHRJznKtV
July 18th 2017, 3:07pm
intercooleronli @intercooleronli
Galectin Therapeutics $GALT & Biohaven Pharmaceutical Holding Co $BHVN Head-To-Head Comparison https://t.co/nY4Dumw9k7
July 18th 2017, 2:07pm
TranscriptDaily @TranscriptDaily
Brokerages Anticipate Galectin Therapeutics Inc. $GALT to Post -$0.13 EPS https://t.co/VlqYP0ZRFZ
July 17th 2017, 8:07pm
DrTranBioSci @DrTranBioSci
Commented on Galectin Therapeutics: Serendipity In Psoriasis, Strength In NASH https://t.co/EWzWZvvH5Y $GALT
July 17th 2017, 3:07pm
SPNewsAnalysis @SPNewsAnalysis
Galectin Therapeutics $GALT Earns Daily News Impact Rating of 0.05 https://t.co/VT5Ckly3BO
July 15th 2017, 12:07pm
NickCinquepalmi @NickCinquepalmi
RT @chaffeybreeze: Galectin Therapeutics Inc. $GALT Lifted to Buy at Zacks Investment Research https://t.co/OcTrWcKXiD
July 15th 2017, 7:07am
chaffeybreeze @chaffeybreeze
US Bancorp DE Acquires 28,087 Shares of Galectin Therapeutics Inc. $GALT https://t.co/vkoIkXoiBk
July 14th 2017, 8:07pm
chaffeybreeze @chaffeybreeze
Galectin Therapeutics Inc. $GALT Lifted to Buy at Zacks Investment Research https://t.co/OcTrWcKXiD
July 14th 2017, 5:07pm
IRAMarketReport @IRAMarketReport
Galectin Therapeutics Inc. $GALT Lifted to Buy at Zacks Investment Research https://t.co/Vsl2WdWZar
July 14th 2017, 5:07pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.